Haoxi Health Technology (HAO) Registration filing summary

Company overview and business model

• Cayman Islands holding structure; China operations run through wholly owned indirect subsidiaries, with no VIE structure and no direct investor ownership in the PRC operating entity.

• Beijing Haoxi provides one-stop online marketing solutions, especially short-video ads; services include planning, production, placement and optimization through media platforms and authorized agents.

• Served 565 advertisers in FY2026, including 230 healthcare companies; since 2018, has served ~2,000 advertisers, mainly in healthcare.

• Bidding Compass supports ad-data analysis; placements use platforms including Toutiao, Douyin, WeChat and Weibo, with established platform relationships since 2018.

Financial performance and metrics

• Revenue was $54.83M in FY2026, $32.80M in FY2025 and $48.52M in FY2024; net loss of $9.54M in FY2026 versus net income of $3.88M in FY2025 and $1.29M in FY2024.

• Audited consolidated financial statements for FY2024–FY2026 are incorporated by reference from the FY2026 annual report.

Use of proceeds and capital allocation

• Net proceeds are intended for project development and commercialization, business growth, primarily working capital, and general corporate purposes.

• A portion may fund acquisitions or investments in technologies, products or businesses; management has broad allocation discretion, with no amounts assigned by purpose in this filing.

• Pending deployment, proceeds are expected to be held in interest-bearing bank accounts; offshore proceeds may face PRC limits on loans, capital contributions and currency transfers.